Korean J Cytopathol.  2000 Dec;11(2):65-73.

Cytologic Features and Distribution of Primary Sites of Malignant Cells in Cerebrospinal Fluid

Affiliations
  • 1Department of Pathology, Seoul National University College of Medicine and Simin HospitalI, Seoul, Korea. pathr@plaza.snu.ac.kr

Abstract

Cytologic evaluation of cerebrospinal fluid(CSF) is an effective mean for diagnosing many disorders involving the central nervous systems(CNS). One of the most important reasons for cytologic examination of CSF is to detect metastatic or primary neoplasms of the CNS. We did a retrospective study of 1,438 CSF specimens obtained between 1992 and 1996. A total of 1,205 adult and 233 pediatric CSF specimens from 947 patients were accessed at the Department of Pathology of Seoul National University Hospital and Children's Hospital, respectively. Among 1,438 CSF cytology specimens, 169 cases(11.8%, 77 patients) including 135 adult cases(59 patients) and 34 pediatric cases(18 patients) were positive for malignant cells. Diagnoses included 60 metastatic carcinomas(adult, 60; pediatric, 0); 46 malignant lymphomas(adult, 44; pediatric, 2); 21 leukemias(adult, 20; pediatric, 1); 4 retinoblastomas(adult, 0; pediatric 4); 2 rhabdomyosarcomas(adult, 0; pediatric, 2); 1 multiple myeloma(adult, 1; pediatric, 0), and 35 primary CNS neoplasms(adult, 10; pediatric, 25). The most commonly identified metastatic carcinomas in adults were adenocarcinoma. Their primary sites were the lung, gastrointestinal tract, and breast in order of frequency. The most common primary CNS neoplasm in children was medulloblastoma.

Keyword

Cerebrospinal fluid; Cytology; Central nervous system; Neoplasm

MeSH Terms

Adenocarcinoma
Adult
Breast
Central Nervous System
Cerebrospinal Fluid*
Child
Diagnosis
Gastrointestinal Tract
Humans
Lung
Medulloblastoma
Pathology
Retrospective Studies
Seoul
Full Text Links
  • KJC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr